Evidence map›Paper›PMID 33182646›Full record

ReviewInternational journal of molecular sciences2020

Coenzyme Q

Carmen J Pastor-Maldonado, Juan M Suárez-Rivero, Suleva Povea-Cabello, Mónica Álvarez-Córdoba, Irene Villalón-García, Manuel Munuera-Cabeza, Alejandra Suárez-Carrillo, Marta Talaverón-Rey, José A Sánchez-Alcázar

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05429229 (Effect of Combined Antioxidant Therapy in Eye Drops on Inflammatory and Oxidative Stress Biomarkers in Tear Film in Patients With Diabetic Retinopathy and Dry Eye Syndrome), which is not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05429229 phase2unknown statusnot on this mapstarted 2021, after this paper: background citation

Effect of Combined Antioxidant Therapy in Eye Drops on Inflammatory and Oxidative Stress Biomarkers in Tear Film in Patients With Diabetic Retinopathy and Dry Eye Syndrome

TypeinterventionalSponsorAdolfo Daniel Rodriguez-CarrizalezRan2021 to 2024Enrolled78ConditionsDry Eye Syndromes, Diabetic Retinopathy, Oxidative Stress, Tear Film DeficiencyArmsVisuXL®, Lagricel PF®, Humylub PF®
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 67 citations in OpenAlex.

  1. Bioavailability and Cellular Compatibility of a Novel Coenzyme QEuropean journal of drug metabolism and pharmacokinetics · 2026
    Trial
  2. Noninvasive instrumental evaluation of coenzyme QBioFactors (Oxford, England) · 2022
    Trial
  3. Women have higher levels of CoQJournal of nutritional science · 2022
    Trial
  4. Review
  5. Optimized CoQ10 deliveryRSC advances · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Understanding coenzyme Q.Physiological reviews · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. CoQAntioxidants (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Carmen J Pastor-MaldonadoCentro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III. Universidad Pablo de Olavide, 41013 Sevilla, Spain.ORCID 0000-0003-1496-5674
Juan M Suárez-RiveroCentro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III. Universidad Pablo de Olavide, 41013 Sevilla, Spain.ORCID 0000-0002-6260-7284
Suleva Povea-CabelloCentro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III. Universidad Pablo de Olavide, 41013 Sevilla, Spain.
Mónica Álvarez-CórdobaCentro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III. Universidad Pablo de Olavide, 41013 Sevilla, Spain.
Irene Villalón-GarcíaCentro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III. Universidad Pablo de Olavide, 41013 Sevilla, Spain.
Manuel Munuera-CabezaCentro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III. Universidad Pablo de Olavide, 41013 Sevilla, Spain.
Alejandra Suárez-CarrilloCentro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III. Universidad Pablo de Olavide, 41013 Sevilla, Spain.
Marta Talaverón-ReyCentro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III. Universidad Pablo de Olavide, 41013 Sevilla, Spain.
José A Sánchez-AlcázarCentro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), and Centro de Investigación Biomédica en Red: Enfermedades Raras, Instituto de Salud Carlos III. Universidad Pablo de Olavide, 41013 Sevilla, Spain.ORCID 0000-0001-9705-1469
Instituto de Salud Carlos III · ES

Funding

Instituto de Salud Carlos III FIS PI16/00786 and FIS PI19/00377
6 · The paper itself

Abstract

The aim of this review is to shed light over the most recent advances in Coenzyme Q

Indexed as

Administration, OralAntioxidantsBiological AvailabilityDrug CompoundingDrug Delivery SystemsHumansLiposomesSolubilityUbiquinoneAntioxidantscoenzyme Q10LiposomesUbiquinoneCoenzyme Q10mitochondriaubiquinone

Identifiers

PMID33182646
PMCPMC7697799
OpenAlexW3106109595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.